Updated:
BTG
BTG is an SEC-registered investment adviser in NEW YORK, NY, registered since 2010. The firm manages $30.1 billion in assets, $29.7 billion on a discretionary...
BTG
BTG is an SEC-registered investment adviser in NEW YORK, NY, registered since 2010. The firm manages $30.1 billion in assets, $29.7 billion on a discretionary basis. BTG has 180 employees and 108 investment advisers.
General information
Firm type
Corporate Investor
Year founded
2004
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
New York
Corporate office
Hemel Hempstead, United Kingdom
Sector focus
Frequently asked questions
Who owns BTG?
SERB Pharmaceuticals serves as the parent company of BTG Specialty Pharmaceuticals following the 2021 acquisition.
What is BTG's relationship to Boston Scientific?
Boston Scientific sold BTG Specialty Pharmaceuticals to SERB Pharmaceuticals in 2021.
Which investors back the SERB/BTG platform?
Charterhouse Capital Partners owns the platform. Partners Group and Merieux Equity Partners participate as co-investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: